The Guide to Pharmacology Ontology

IRI:
http://rdf.guidetopharmacology.org/ns/gtpo
Date:
20/09/2017
Current version:
0.3
Authors:
Alasdair J G Gray (orcid:0000-0002-5711-4872)
Liam Bruce
Other visualisation:
Ontology source

Abstract

The Guide to Pharmacoloty Ontoloty (GTPO) is used to define the entities which appear in the Guide to Pharmacology RDF representation. It is based on the Guide to Pharmacology glossary of terms.

Table of Content

  1. Classes
  2. Object Properties
  3. Data Properties
  4. General Axioms
  5. Namespace Declarations

Classes

actionc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#Action

Class describing different interaction actions, defined by Guide to Pharmacology

has sub-classes
activation actionc, agonist actionc, antagonist actionc, biased agonist actionc, binding actionc, biphasic actionc, competitive actionc, feedback inhibition actionc, full agonist actionc, inhibition actionc, inverse agonist actionc, irreversible agonist actionc, irreversible inhibition actionc, mixed actionc, negative actionc, neutral actionc, no actionc, non competitive actionc, partial agonist actionc, pore blocker actionc, positive actionc, potentiation actionc, slows inactivation actionc, unknownc, voltage dependent inbibition actionc
is in range of
has actionop

activation actionc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#ActivationAction

has super-classes
actionc

activator interactionc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#ActivatorInteraction

has super-classes
interactionc

agonist actionc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#AgonistAction

has super-classes
actionc

agonist interactionc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#AgonistInteraction

has super-classes
interactionc

allosteric modulator interactionc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#AllostericModulatorInteraction

has super-classes
interactionc

annotated awaiting reviewc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#AnnotatedAwaitingReview

has super-classes
annotation statusc

annotated expert reviewedc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#AnnotatedExpertReviewed

has super-classes
annotation statusc

annotation statusc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#AnnotationStatus

Class describing annotation status of targets, defined by Guide to Pharmacology

has sub-classes
annotated awaiting reviewc, annotated expert reviewedc, under developmentc
is in range of
has annotation statusop

antagonist actionc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#AntagonistAction

has super-classes
actionc

antagonist interactionc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#AntagonistInteraction

has super-classes
interactionc

antibody interactionc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#AntibodyInteraction

has super-classes
interactionc
is disjoint with
inorganic ligandc, metabolite ligandc, natural product ligandc, peptide ligandc, synthetic organic ligandc

antibody ligandc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#AntibodyLigand

has super-classes
ligandc

biased agonist actionc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#BiasedAgonistAction

has super-classes
actionc

binding actionc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#BindingAction

has super-classes
actionc

biphasic actionc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#BiphasicAction

has super-classes
actionc

catalytic receptor target familyc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#CatalyticReceptorTargetFamily

has super-classes
target familyc
is disjoint with
enzyme target familyc, g protein coupled receptor target familyc, grouping target familyc, ligand gated ion channel target familyc, ligand target familyc, nuclear hormone receptor target familyc, other ion channel target familyc, other protein target familyc, transporter target familyc, voltage gated ion channel target familyc

channel blocker interactionc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#ChannelBlockerInteraction

has super-classes
interactionc

competitive actionc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#CompetitiveAction

has super-classes
actionc

enzyme target familyc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#EnzymeTargetFamily

has super-classes
target familyc
is disjoint with
catalytic receptor target familyc, g protein coupled receptor target familyc, grouping target familyc, ligand gated ion channel target familyc, ligand target familyc, nuclear hormone receptor target familyc, other ion channel target familyc, other protein target familyc, transporter target familyc, voltage gated ion channel target familyc

feedback inhibition actionc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#FeedbackInhibitionAction

has super-classes
actionc

full agonist actionc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#FullAgonistAction

has super-classes
actionc

g protein coupled receptor target familyc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#GProteinCoupledReceptorTargetFamily

has super-classes
target familyc
is disjoint with
catalytic receptor target familyc, enzyme target familyc, grouping target familyc, ligand gated ion channel target familyc, ligand target familyc, nuclear hormone receptor target familyc, other ion channel target familyc, other protein target familyc, transporter target familyc, voltage gated ion channel target familyc

gating inhibitor interactionc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#GatingInhibitorInteraction

has super-classes
interactionc

grouping target familyc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#GroupingTargetFamily

has super-classes
target familyc
is disjoint with
catalytic receptor target familyc, enzyme target familyc, g protein coupled receptor target familyc, ligand gated ion channel target familyc, ligand target familyc, nuclear hormone receptor target familyc, other ion channel target familyc, other protein target familyc, transporter target familyc, voltage gated ion channel target familyc

inhibition actionc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#InhibitionAction

has super-classes
actionc

inhibitor interactionc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#InhibitorInteraction

has super-classes
interactionc

inorganic ligandc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#InorganicLigand

has super-classes
ligandc
is disjoint with
antibody interactionc, metabolite ligandc, natural product ligandc, peptide ligandc, synthetic organic ligandc

interactionc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#Interaction

Class describing the interactions between chemicals and proteins stored in the Guide to Pharmacology data

has sub-classes
activator interactionc, agonist interactionc, allosteric modulator interactionc, antagonist interactionc, antibody interactionc, channel blocker interactionc, gating inhibitor interactionc, inhibitor interactionc, subunit specific interactionc
is in domain of
has actionop, has affinityop, has high valuedp, has ligandop, has low valuedp, has median valuedp, has referenceop, has targetop

inverse agonist actionc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#InverseAgonistAction

has super-classes
actionc

irreversible agonist actionc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#IrreversibleAgonistAction

has super-classes
actionc

irreversible inhibition actionc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#IrreversibleInhibitionAction

has super-classes
actionc

ligandc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#Ligand

Class describing the chemicals stored in the Guide to Pharmacology data

has sub-classes
antibody ligandc, inorganic ligandc, metabolite ligandc, natural product ligandc, peptide ligandc, synthetic organic ligandc
is in domain of
approveddp, canonical s m i l e sdp, commentdp, in ch i i ddp, in ch i k e ydp, isomeric s m i l e sdp, iupac namedp, ligand namedp, synonymdp
is in range of
has ligandop

ligand gated ion channel target familyc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#LigandGatedIonChannelTargetFamily

has super-classes
target familyc
is disjoint with
catalytic receptor target familyc, enzyme target familyc, g protein coupled receptor target familyc, grouping target familyc, ligand target familyc, nuclear hormone receptor target familyc, other ion channel target familyc, other protein target familyc, transporter target familyc, voltage gated ion channel target familyc

ligand target familyc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#LigandTargetFamily

has super-classes
target familyc
is disjoint with
catalytic receptor target familyc, enzyme target familyc, g protein coupled receptor target familyc, grouping target familyc, ligand gated ion channel target familyc, nuclear hormone receptor target familyc, other ion channel target familyc, other protein target familyc, transporter target familyc, voltage gated ion channel target familyc

metabolite ligandc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#MetaboliteLigand

has super-classes
ligandc
is disjoint with
antibody interactionc, inorganic ligandc, natural product ligandc, peptide ligandc, synthetic organic ligandc

mixed actionc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#MixedAction

has super-classes
actionc

natural product ligandc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#NaturalProductLigand

has super-classes
ligandc
is disjoint with
antibody interactionc, inorganic ligandc, metabolite ligandc, peptide ligandc, synthetic organic ligandc

negative actionc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#NegativeAction

has super-classes
actionc

neutral actionc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#NeutralAction

has super-classes
actionc

no actionc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#NoAction

has super-classes
actionc

non competitive actionc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#NonCompetitiveAction

has super-classes
actionc

nuclear hormone receptor target familyc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#NuclearHormoneReceptorTargetFamily

has super-classes
target familyc
is disjoint with
catalytic receptor target familyc, enzyme target familyc, g protein coupled receptor target familyc, grouping target familyc, ligand gated ion channel target familyc, ligand target familyc, other ion channel target familyc, other protein target familyc, transporter target familyc, voltage gated ion channel target familyc

other ion channel target familyc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#OtherIonChannelTargetFamily

has super-classes
target familyc
is disjoint with
catalytic receptor target familyc, enzyme target familyc, g protein coupled receptor target familyc, grouping target familyc, ligand gated ion channel target familyc, ligand target familyc, nuclear hormone receptor target familyc, other protein target familyc, transporter target familyc, voltage gated ion channel target familyc

other protein target familyc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#OtherProteinTargetFamily

has super-classes
target familyc
is disjoint with
catalytic receptor target familyc, enzyme target familyc, g protein coupled receptor target familyc, grouping target familyc, ligand gated ion channel target familyc, ligand target familyc, nuclear hormone receptor target familyc, other ion channel target familyc, transporter target familyc, voltage gated ion channel target familyc

partial agonist actionc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#PartialAgonistAction

has super-classes
actionc

peptide ligandc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#PeptideLigand

has super-classes
ligandc
is disjoint with
antibody interactionc, inorganic ligandc, metabolite ligandc, natural product ligandc, synthetic organic ligandc

pore blocker actionc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#PoreBlockerAction

has super-classes
actionc

positive actionc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#PositiveAction

has super-classes
actionc

potentiation actionc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#PotentiationAction

has super-classes
actionc

slows inactivation actionc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#SlowsInactivationAction

has super-classes
actionc

subunit specific interactionc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#SubunitSpecificInteraction

has super-classes
interactionc

synthetic organic ligandc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#SyntheticOrganicLigand

has super-classes
ligandc
is disjoint with
antibody interactionc, inorganic ligandc, metabolite ligandc, natural product ligandc, peptide ligandc

targetc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#Target

Class describing the different proteins stored in the Guide to Pharmacology data

is in domain of
has annotation statusop, has target familyop, nomenclaturedp
is in range of
has targetop

target familyc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#TargetFamily

Class describing families of proteins stored in the Guide to Pharmacology data

has sub-classes
catalytic receptor target familyc, enzyme target familyc, g protein coupled receptor target familyc, grouping target familyc, ligand gated ion channel target familyc, ligand target familyc, nuclear hormone receptor target familyc, other ion channel target familyc, other protein target familyc, transporter target familyc, voltage gated ion channel target familyc
is in domain of
target family namedp
is in range of
has target familyop

transporter target familyc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#TransporterTargetFamily

has super-classes
target familyc
is disjoint with
catalytic receptor target familyc, enzyme target familyc, g protein coupled receptor target familyc, grouping target familyc, ligand gated ion channel target familyc, ligand target familyc, nuclear hormone receptor target familyc, other ion channel target familyc, other protein target familyc, voltage gated ion channel target familyc

under developmentc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#UnderDevelopment

has super-classes
annotation statusc

unknownc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#Unknown

has super-classes
actionc

voltage dependent inbibition actionc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#VoltageDependentInbibitionAction

has super-classes
actionc

voltage gated ion channel target familyc back to ToC or Class ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#VoltageGatedIonChannelTargetFamily

has super-classes
target familyc
is disjoint with
catalytic receptor target familyc, enzyme target familyc, g protein coupled receptor target familyc, grouping target familyc, ligand gated ion channel target familyc, ligand target familyc, nuclear hormone receptor target familyc, other ion channel target familyc, other protein target familyc, transporter target familyc

Object Properties

has actionop back to ToC or Object Property ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#hasAction

Action of an interaction

has domain
interactionc
has range
actionc

has affinityop back to ToC or Object Property ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#hasAffinity

Reference to a node describing interaction affinity values and units

has domain
interactionc
has range
affinityc

has annotation statusop back to ToC or Object Property ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#hasAnnotationStatus

Annotation status of a given target

has domain
targetc
has range
annotation statusc

has ligandop back to ToC or Object Property ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#hasLigand

ligand participant of an interaction

has domain
interactionc
has range
ligandc

has refop back to ToC or Object Property ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#hasRef

Reference to Blank node pair, containing cross reference and taxonomy

has domain
ligandc or targetc

has referenceop back to ToC or Object Property ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#hasReference

Reference to PubMed id of article describing interaction

has domain
interactionc

has speciesop back to ToC or Object Property ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#hasSpecies

Cross reference to NCBI taxonomy

has domain
interactionc or ligandc or targetc

has targetop back to ToC or Object Property ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#hasTarget

target participant of an interaction

has domain
interactionc
has range
targetc

has target familyop back to ToC or Object Property ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#hasTargetFamily

target family of a target

has domain
targetc
has range
target familyc

has unitop back to ToC or Object Property ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#hasUnit

Cross reference to unit description from BAO ontology

has domain
affinityc

xrefop back to ToC or Object Property ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#xref

Cross reference to external database

has domain
ligandc or targetc

Data Properties

approveddp back to ToC or Data Property ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#approved

Approval status of a ligand

has domain
ligandc
has range
boolean

canonical s m i l e sdp back to ToC or Data Property ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#canonicalSMILES

canonical SMILES, describing a ligand

has domain
ligandc
has range
string

commentdp back to ToC or Data Property ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#comment

Guide to Pharmacology comments on a ligand

has domain
ligandc
has range
string

has high valuedp back to ToC or Data Property ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#hasHighValue

High value of an interaction affinity, also has low value

has domain
interactionc
has range
double

has low valuedp back to ToC or Data Property ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#hasLowValue

Low value of an interaction affinity, also has high value

has domain
interactionc
has range
double

has median valuedp back to ToC or Data Property ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#hasMedianValue

Median value of an interaction affinity

has domain
interactionc
has range
double

in ch i i ddp back to ToC or Data Property ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#InChIID

InChI identifier for a ligand

has domain
ligandc
has range
string

in ch i k e ydp back to ToC or Data Property ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#InChIKEY

InChI key defining a ligand

has domain
ligandc
has range
string

isomeric s m i l e sdp back to ToC or Data Property ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#isomericSMILES

isomeric SMILES, describing a ligand

has domain
ligandc
has range
string

iupac namedp back to ToC or Data Property ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#iupacName

name of a ligand, defined by the IUPAC

has domain
ligandc
has range
string

ligand namedp back to ToC or Data Property ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#ligandName

the name of a chemical ligand

has domain
ligandc
has range
string

nomenclaturedp back to ToC or Data Property ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#nomenclature

nomenclature, the name of a target

has domain
targetc
has range
string

synonymdp back to ToC or Data Property ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#synonym

Synony of a ligand

has domain
ligandc
has range
string

target family namedp back to ToC or Data Property ToC

IRI: http://rdf.guidetopharmacology.org/ns/gtpo#targetFamilyName

name for target family

has domain
target familyc
has range
string

General Axioms

All Disjoint Classes back to ToC

antibody interactionc, inorganic ligandc, metabolite ligandc, natural product ligandc, peptide ligandc, synthetic organic ligandc

All Disjoint Classes back to ToC

catalytic receptor target familyc, enzyme target familyc, g protein coupled receptor target familyc, grouping target familyc, ligand gated ion channel target familyc, ligand target familyc, nuclear hormone receptor target familyc, other ion channel target familyc, other protein target familyc, transporter target familyc, voltage gated ion channel target familyc

Namespace Declarations back to ToC

default namespace
http://rdf.guidetopharmacology.org/ns/gtpo#
ns
http://rdf.guidetopharmacology.org/ns/
owl
http://www.w3.org/2002/07/owl#
rdf
http://www.w3.org/1999/02/22-rdf-syntax-ns#
rdfs
http://www.w3.org/2000/01/rdf-schema#
terms
http://purl.org/dc/terms/
vann
http://purl.org/vocab/vann/
xsd
http://www.w3.org/2001/XMLSchema#

This HTML document was obtained by processing the OWL ontology source code through LODE, Live OWL Documentation Environment, developed by Silvio Peroni.